Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In …

Dec 25, 2024 · We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against ...

27%
OFF

Should You Buy Vertex Pharmaceuticals On The Dip Before

2 weeks from now

Dec 22, 2024 · Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% from January through a peak in November. The company, the global ...

nasdaq.com

3%
OFF

Which Is A Better Investment, BeiGene, Ltd. Or Vertex …

2 weeks from now

6 days ago · Vertex Pharmaceuticals Incorporated’s stock is up 2.3% in 2025, up 1.6% in the previous five trading days and down 1.67% in the past year. Currently, Vertex Pharmaceuticals Incorporated does not have a price-earnings ratio. Vertex Pharmaceuticals Incorporated’s …

aaii.com

5%
OFF

Is Vertex Pharmaceuticals Stock (VRTX), A Good Investment?

2 weeks from now

Nov 14, 2024 · Vertex Pharmaceuticals Incorporated does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Vertex Pharmaceuticals Incorporated’s trailing 12-month revenue is $10.6 billion with a -4.5% profit margin. ... Vertex Pharmaceuticals …

aaii.com

$496.48
OFF

Wells Fargo Issues A Buy Rating On Vertex Pharmaceuticals (VRTX)

2 weeks from now

2 days ago · Vertex Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $496.48. See the top stocks recommended by analysts >> VRTX market cap is currently $106.1B and ...

businessinsider.com

7%
OFF

If You Invested $1000 In This Stock 20 Years Ago, You Would

2 weeks from now

5 days ago · Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 11.7% on an annualized basis producing an average annual return of 20.1%. Currently, Vertex Pharmaceuticals has a ...

benzinga.com

93%
OFF

10 Stocks That Will Make You Rich In 2025 - Insider Monkey

2 weeks from now

Dec 24, 2024 · It is one of the 10 stocks that can make you rich in 2025. 9. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Analysts Upside Potential: 35.93%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ...

insidermonkey.com

$106
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect

2 weeks from now

2 days ago · Vertex Pharmaceuticals Incorporated (VRTX), headquartered in Boston, Massachusetts, is a global leader in biotechnology and precision medicine. With a market cap of $106.1 billion, Vertex pioneers ...

nasdaq.com

56%
OFF

Vertex Pharmaceuticals On Pace For Largest Percent Increase Since ...

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $489.63, up $16.83 or 3.56% --Would be highest close since Oct. 17, 2024, when it closed at $498.73 --On pace for largest percent ...

morningstar.com

62%
OFF

Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You …

2 weeks from now

1 day ago · In the latest market close, Vertex Pharmaceuticals (VRTX) reached $409.56, with a -0.62% movement compared to the previous day. This change was narrower than the S&P 500's 1.54% loss on the day ...

yahoo.com

FAQs about Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In … Coupon?

Is Vertex Pharmaceuticals Inc (VRTX) a good investment?

While we acknowledge the potential of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. ...

Is Vertex Pharmaceuticals a good stock to buy now?

Right now, Vertex Pharmaceuticals possesses a Zacks Rank of #3 (Hold). Valuation is also important, so investors should note that Vertex Pharmaceuticals has a Forward P/E ratio of 22.58 right now. For comparison, its industry has an average Forward P/E of 22.58, which means Vertex Pharmaceuticals is trading at no noticeable deviation to the group. ...

How much did Vertex Pharmaceuticals make in the third quarter?

The company's bottom line came in at $1.045 billion, or $4.01 per share. This compares with $1.035 billion, or $3.97 per share, in last year's third quarter. Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.143 billion or $4.38 per share for the period. ...

What will Vertex Pharmaceuticals' earnings report look like?

The investment community will be closely monitoring the performance of Vertex Pharmaceuticals in its forthcoming earnings report. It is anticipated that the company will report an EPS of $4, marking a 4.76% fall compared to the same quarter of the previous year. ...

Is vertex a good investment?

Vertex is growing beyond its highly successful cystic fibrosis business and into other areas of healthcare. The added growth opportunities should accelerate its growth rate, which slowed down last year. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. ...

Is vertex a profitable company?

Vertex is a profitable company with substantial financial resources and top tier in house scientific expertise. They are well positioned to maneuver through the scientific challenges that inevitably arise during drug development. ...